1.3500
+0.0020
+(0.15%)
At close: April 17 at 5:35:14 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
22,989
22,989
-24,746
-87,444
-104,562
Investing Cash Flow
-102,808
-102,808
-15,510
-2,761
7,279
Financing Cash Flow
89,113
89,113
82,865
1,145
47,525
End Cash Position
143,251
143,251
136,708
93,216
185,636
Capital Expenditure
-3,843
-3,843
-1,073
-2,441
-18,556
Issuance of Capital Stock
82,822
82,822
67,936
--
44,638
Issuance of Debt
23,201
23,201
29,671
5,750
--
Repayment of Debt
-16,063
-16,063
-16,191
-12,354
-10,641
Repurchase of Capital Stock
-469
--
--
-569
--
Free Cash Flow
19,146
19,146
-25,819
-89,885
-123,118
12/31/2021 - 2/7/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DBV.PA DBV Technologies S.A.
1.3280
+3.59%
MEDCL.PA MedinCell S.A.
14.11
+0.28%
IPH.PA Innate Pharma S.A.
1.7480
-0.46%
ALSEN.PA Sensorion SA
0.1700
-26.09%
MAH0.HA Mereo BioPharma Group PLC
1.9250
+10.00%
MAH0.HM Mereo BioPharma Group PLC
1.9250
+10.00%
MAH0.F Mereo BioPharma Group plc
1.8200
+6.43%
HPHA.DE Heidelberg Pharma AG
2.6100
+0.38%
RVU.WA Ryvu Therapeutics S.A.
28.40
+4.03%
POXEL.PA Poxel S.A.
0.3810
-22.56%